N 343 2.5 (Glyburide 2.5 mg)
Pill imprint N 343 2.5 has been identified as Glyburide 2.5 mg.
Glyburide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glyburide 2.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- N 343 2.5
- 2.5 mg
- 8.00 mm
- Prescription only
- Drug Class:
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- Inactive Ingredients:
- microcrystalline cellulose
sodium starch glycolate type A potato
FD&C Yellow No. 6
|NDC Code||Manufacturer / Repackager|
|51079-0872||UDL Laboratories Inc|
|66336-0028||Dispensing Solutions Inc. (repackager)|
|35356-0360||Lake Erie Medical and Surgical Supply (repackager)|
|55289-0606||PDRX Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
More about glyburide
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.